Detailansicht

Wissensnetz

Person

Martin Hoenigl

Arzt

Name	Martin Hoenigl
Ort	San Diego, Calif. (Wirkungsort) USA
Geschlecht	männlich
Akademischer Grad bzw. Titel	MD
Beruf	Arzt (charakteristischer Beruf) Internist
Weitere Angaben	M.D., Ass. Prof., FECMM, holds an appointment as Assistant Professor at the Division of Infectious Diseases of the University of California, San Diego (UCSD). He obtained his venia docendi in internal medicine in 2012; His research is focused on clinical mycology, with a particular focus on diagnosis and lately COVID-associated aspergillosis. He serves as the current president of the European Confederation of Medical Mycology (ECMM)
Datensatztyp	Person
GND-Nummer	1237459737
Datensatz-ID	1237459737
Beteiligt an alle anzeigen A Global Analysis of Cases of Mucormycosis Recorded in the European Confederation of Medical Mycology / International Society for Human and Animal Mycology (ECMM / ISHAM) Zygomyco.net Registry from 2009 to 2022 Diagnosis and treatment of invasive pulmonary aspergillosis in critically ill intensive care patients: executive summary of the German national guideline (AWMF 113-005) Advancing Patient Advocacy in Mycology: Cultivating Collaboration in Education, Research, and Policy Insights from Three Pan-European Multicentre Studies on Invasive Candida Infections and Outlook to ECMM Candida IV Comparative Analysis of the Clarus Aspergillus Galactomannan Enzyme Immunoassay Prototype for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid Antifungal prophylaxis of COVID-19 associated pulmonary aspergillosis in ventilated patients: one solution does not fit all Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey Exploring European Consensus About the Remaining Treatment Challenges and Subsequent Opportunities to Improve the Management of Invasive Fungal Infection (IFI) in the Intensive Care Unit Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM ECMM Center of Excellence: A Shared Vision for the Diagnosis and Treatment of Fungal Infections Circulatory Inflammatory Proteins as Early Diagnostic Biomarkers for Invasive Aspergillosis in Patients with Hematologic Malignancies—an Exploratory Study Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey COVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape Treatment of Fusarium Infection of the Central Nervous System: A Review of Past Cases to Guide Therapy for the Ongoing 2023 Outbreak in the United States and Mexico Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study Treatment of Invasive Aspergillosis: How It’s Going, Where It’s Heading COVID-19-associated fungal infections Dark Mold Infections in Solid Organ Transplant Recipients COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update SuPAR levels in BAL fluid from patients with acute respiratory distress syndrome—a pilot study Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature Plasma (1 → 3)-β-d-glucan and suPAR levels correlate with neurocognitive performance in people living with HIV on antiretroviral therapy: a CHARTER analysis Correction to: (New) Methods for Detection of Aspergillus fumigatus Resistance in Clinical Samples (New) Methods for Detection of Aspergillus fumigatus Resistance in Clinical Samples Self-initiated continuation of and adherence to HIV pre-exposure prophylaxis (PrEP) after PrEP demonstration project roll-off in men who have sex with men: associations with risky decision making, impulsivity/disinhibition, and sensation seeking Molecular Epidemiology of the HIV Epidemic in Three German Metropolitan Regions – Cologne/Bonn, Munich and Hannover, 1999–2016 Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status Performance of the FilmArray Blood culture identification panel in positive blood culture bottles and cerebrospinal fluid for the diagnosis of sepsis and meningitis suPAR remains uninfluenced by surgery in septic patients with bloodstream infection Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients Point of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet? Repeat HIV-testing is associated with an increase in behavioral risk among men who have sex with men: a cohort study Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients Toxocarosis and putative DRESS syndrome in an oncological patient: a case report Progressive alveolar echinococcosis after discontinuation of anthelmintic therapy Ventilator-associated pneumonia caused by OXA-48-producing Escherichia coli complicated by ciprofloxacin-associated rhabdomyolysis

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Martin Hoenigl

A Global Analysis of Cases of Mucormycosis Recorded in the European Confederation of Medical Mycology / International Society for Human and Animal Mycology (ECMM / ISHAM) Zygomyco.net Registry from 2009 to 2022

Diagnosis and treatment of invasive pulmonary aspergillosis in critically ill intensive care patients: executive summary of the German national guideline (AWMF 113-005)

Advancing Patient Advocacy in Mycology: Cultivating Collaboration in Education, Research, and Policy

Insights from Three Pan-European Multicentre Studies on Invasive Candida Infections and Outlook to ECMM Candida IV

Comparative Analysis of the Clarus Aspergillus Galactomannan Enzyme Immunoassay Prototype for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid

Antifungal prophylaxis of COVID-19 associated pulmonary aspergillosis in ventilated patients: one solution does not fit all

Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

Exploring European Consensus About the Remaining Treatment Challenges and Subsequent Opportunities to Improve the Management of Invasive Fungal Infection (IFI) in the Intensive Care Unit

Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM

ECMM Center of Excellence: A Shared Vision for the Diagnosis and Treatment of Fungal Infections

Circulatory Inflammatory Proteins as Early Diagnostic Biomarkers for Invasive Aspergillosis in Patients with Hematologic Malignancies—an Exploratory Study

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

COVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis

Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis

Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape

Treatment of Fusarium Infection of the Central Nervous System: A Review of Past Cases to Guide Therapy for the Ongoing 2023 Outbreak in the United States and Mexico

Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study

Treatment of Invasive Aspergillosis: How It’s Going, Where It’s Heading

COVID-19-associated fungal infections

Dark Mold Infections in Solid Organ Transplant Recipients

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin

Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study

COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges

Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry

The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update

SuPAR levels in BAL fluid from patients with acute respiratory distress syndrome—a pilot study

Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature

Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature

Plasma (1 → 3)-β-d-glucan and suPAR levels correlate with neurocognitive performance in people living with HIV on antiretroviral therapy: a CHARTER analysis

Correction to: (New) Methods for Detection of Aspergillus fumigatus Resistance in Clinical Samples

(New) Methods for Detection of Aspergillus fumigatus Resistance in Clinical Samples

Self-initiated continuation of and adherence to HIV pre-exposure prophylaxis (PrEP) after PrEP demonstration project roll-off in men who have sex with men: associations with risky decision making, impulsivity/disinhibition, and sensation seeking

Molecular Epidemiology of the HIV Epidemic in Three German Metropolitan Regions – Cologne/Bonn, Munich and Hannover, 1999–2016

Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives

Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status

Performance of the FilmArray Blood culture identification panel in positive blood culture bottles and cerebrospinal fluid for the diagnosis of sepsis and meningitis

suPAR remains uninfluenced by surgery in septic patients with bloodstream infection

Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients

Point of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet?

Repeat HIV-testing is associated with an increase in behavioral risk among men who have sex with men: a cohort study

Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients

Toxocarosis and putative DRESS syndrome in an oncological patient: a case report

Progressive alveolar echinococcosis after discontinuation of anthelmintic therapy

Ventilator-associated pneumonia caused by OXA-48-producing Escherichia coli complicated by ciprofloxacin-associated rhabdomyolysis